Cargando…

Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma

Head and neck cancer (HNC) is the sixth cause of cancer-related death worldwide. Head and neck squamous cells carcinoma (HNSCC) is the most frequent subtype of HNC. The development of HNSCC is associated to alcohol consumption, smoking or infection by high-risk human Papillomavirus (HR-HPV). Althoug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz-Gregorio, Alfredo, Martínez-Ramírez, Imelda, Pedraza-Chaverri, José, Lizano, Marcela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406552/ https://www.ncbi.nlm.nih.gov/pubmed/30764513 http://dx.doi.org/10.3390/cancers11020182

Ejemplares similares

E6 Oncoproteins from High-Risk Human Papillomavirus Induce Mitochondrial Metabolism in a Head and Neck Squamous Cell Carcinoma Model
por: Cruz-Gregorio, Alfredo, et al.
Publicado: (2019)

Regulation of Cellular Metabolism by High-Risk Human Papillomaviruses
por: Martínez-Ramírez, Imelda, et al.
Publicado: (2018)

Perspectives of lipid metabolism reprogramming in head and neck squamous cell carcinoma: An overview
por: Miao, Xiangwan, et al.
Publicado: (2022)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

The Polyphenols α-Mangostin and Nordihydroguaiaretic Acid Induce Oxidative Stress, Cell Cycle Arrest, and Apoptosis in a Cellular Model of Medulloblastoma
por: Rojas-Ochoa, Alberto, et al.
Publicado: (2021)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Cancer Cell Metabolism Reprogramming and Its Potential Implications on Therapy in Squamous Cell Carcinoma of the Head and Neck: A Review
por: Perri, Francesco, et al.
Publicado: (2022)

Inhibitors of Ceramide- and Sphingosine-Metabolizing Enzymes as Sensitizers in Radiotherapy and Chemotherapy for Head and Neck Squamous Cell Carcinoma
por: Yura, Yoshiaki, et al.
Publicado: (2020)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
por: Fasano, Morena, et al.
Publicado: (2022)

The impact of national holidays on postoperative radiotherapy of squamous cell carcinoma of the head and neck
por: Kim, Michael S., et al.
Publicado: (2023)

The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma
por: Boschert, Verena, et al.
Publicado: (2020)

Identification of a metabolic reprogramming‐related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis
por: Qiang, Weijie, et al.
Publicado: (2022)

Fusobacterium nucleatum-triggered purine metabolic reprogramming drives tumorigenesis in head and neck carcinoma
por: Li, Feiran, et al.
Publicado: (2023)

Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma?
por: van der Veen, Julie, et al.
Publicado: (2017)

Glutathione S-transferase Polymorphisms in Head and Neck Squamous Cell Carcinoma Treated with Chemotherapy and/or Radiotherapy
por: Maniglia, Mauricio Pereira, et al.
Publicado: (2020)

Overcoming the Impact of Hypoxia in Driving Radiotherapy Resistance in Head and Neck Squamous Cell Carcinoma
por: Hill, Rhianna M., et al.
Publicado: (2022)

Role of HPV18 E6 in PKB signal transduction pathways
por: Contreras, Adriana, et al.
Publicado: (2007)

Individualized elective irradiation of the clinically node‐negative neck in definitive radiotherapy for head and neck squamous cell carcinoma
por: Kou, Jia, et al.
Publicado: (2021)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
por: Lechien, Jérôme R., et al.
Publicado: (2020)

Mutated FANCA Gene Role in the Modulation of Energy Metabolism and Mitochondrial Dynamics in Head and Neck Squamous Cell Carcinoma
por: Bertola, Nadia, et al.
Publicado: (2022)

Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
por: Veyrat, Mathieu, et al.
Publicado: (2016)

Prospective observational study of carbon‐ion radiotherapy for non‐squamous cell carcinoma of the head and neck
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy
por: Grossberg, Aaron J., et al.
Publicado: (2018)

Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
por: Jacinto, Alexandre Arthur, et al.
Publicado: (2018)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
por: Haehl, Erik, et al.
Publicado: (2021)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region
por: Polanowski, Paweł, et al.
Publicado: (2022)

Impact of upgraded radiotherapy system on outcomes in postoperative head and neck squamous cell carcinoma patients
por: Koiwai, Keiichiro, et al.
Publicado: (2022)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
por: Mehibel, Manal, et al.
Publicado: (2018)

Pathological Similarities in the Development of Papillomavirus-Associated Cancer in Humans, Dogs, and Cats
por: Cruz-Gregorio, Alfredo, et al.
Publicado: (2022)

Repositioning Fenofibrate to Reactivate p53 and Reprogram the Tumor-Immune Microenvironment in HPV+ Head and Neck Squamous Cell Carcinoma
por: O’Neill, W. Quinn, et al.
Publicado: (2022)

Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
por: Hurník, Pavel, et al.
Publicado: (2022)

Associations of GWAS-Identified Risk Loci with Progression, Efficacy and Toxicity of Radiotherapy of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy
por: Li, Qinghuan, et al.
Publicado: (2021)

Correlation between egfr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma
por: Pedicini, Piernicola, et al.
Publicado: (2012)

Ultrasound delta-radiomics during radiotherapy to predict recurrence in patients with head and neck squamous cell carcinoma
por: Fatima, Kashuf, et al.
Publicado: (2021)

Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Sun, Chuyao, et al.
Publicado: (2021)

Salvage Post-Operative Stereotatic Ablative Radiotherapy for Re-Current Squamous Cell Carcinoma of Head and Neck
por: Pellizzon, Antonio, et al.
Publicado: (2022)

Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy—A Systematic Review
por: Schanne, Daniel H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pihvs1h2a76kau2k4jlrgki48e